Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Farxiga/Forxiga (dapagliflozin) Disease area(s): Metabolic diseases Manufacturer(s): AstraZeneca 2024 Sales (USD): $7.72 billion Why it sold so well: In 2024, AstraZenecas Farxiga achieved robust sales growth, with revenues increasing by 21% year-over-year to $1.9 billion in the fourth quarter alone and by 28% compared to 2023, making it the companys top seller in 2024
I also love thinly sliced deli turkey or ham rolled up with a little cream cheese
Health care providers also prescribe it off-label for weight loss because clinical evidence has shown the drug can prompt weight loss in those with obesity or excess weight
The TRIUMPH study series is evaluating the compound across several indications including obesity, type 2 diabetes, osteoarthritis, obstructive sleep apnea, chronic low back pain, cardiovascular and renal outcomes, and MASLD
US$ 23.25
:max_bytes(150000):strip_icc()/VWH-GettyImages-2276706586.jpg-4e49ad1f948143ed99767b89bf0289d7.jpg)
US$ 29.37
US$ 26.64
US$ 28.57
US$ 29.57
US$ 26.28
US$ 22.50
